<DOC>
	<DOCNO>NCT02068898</DOCNO>
	<brief_summary>The study assess bioavailability XS003 give single oral dose compare Tasigna® give single oral dose healthy male subject .</brief_summary>
	<brief_title>Pharmacokinetic Comparison XS003 Tasigna</brief_title>
	<detailed_description>The study consist two part , first part compose pilot part compare bioavailability single oral dos XS003 compare Tasigna® give single oral dose healthy male subject . The second part food-effect part assess food effect single oral dose XS003 healthy male subject either fed fast . The study also evaluate safety tolerability XS003 secondary objective .</detailed_description>
	<criteria>Healthy male Age 18 55 year age Body mass index ( BMI ) 18.0 29.0 kg/m2 Laboratory parameter normal range Females Current smoker smoke within last 12 month . A breath carbon monoxide read great 10 ppm screening . Serious adverse reaction serious hypersensitivity drug formulation excipients . History cardiovascular , renal , hepatic , chronic respiratory gastrointestinal disease judge investigator . Subject QTcF &gt; 450 m base ECG screen history additional risk factor Torsades de Pointe ( e.g . hypokalaemia , hypomagnesemia , family history long QT syndrome )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>